Alloush Ramsey 4
4 · Journey Medical Corp · Filed Apr 24, 2026
Research Summary
AI-generated summary of this filing
Journey Medical (DERM) COO Alloush Ramsey Receives RSU Award & Options
What Happened
Alloush Ramsey, Chief Operating Officer of Journey Medical Corp (DERM), was granted equity awards on April 22, 2026: 46,863 restricted stock units (RSUs) and 62,795 stock options. The Form 4 reports an acquisition price of $0.00 for both grants (these are compensation awards, not purchases or sales). The RSUs and options vest in equal annual installments over three years.
Key Details
- Transaction date: April 22, 2026; Form 4 filed April 24, 2026 (appears timely).
- Grants reported: 46,863 RSUs (reported as award A) and 62,795 stock options (reported as derivative award A). Reported acquisition price: $0.00 (no cash paid).
- RSU vesting (per footnote): 15,621 shares vest on each of Apr 22, 2027; Apr 22, 2028; Apr 22, 2029.
- Option vesting (per footnote): 20,932 options vest on Apr 22, 2027; 20,932 on Apr 22, 2028; 20,931 on Apr 22, 2029.
- Shares owned after transaction: not specified in the provided summary of the filing.
- Footnotes: F1/F3 detail the three-year vesting schedule; F2 notes inclusion of restricted stock units that vest over various periods. No 10b5-1 plan, tax withholding, or cashless-exercise language was disclosed in the summary provided.
Context
RSUs convert to common shares as they vest; stock options give the holder the right to buy shares at a set exercise price once vested (the exercise price and post-vesting actions were not disclosed in the summary). These grants are routine executive compensation and do not represent an open-market purchase or sale by the insider. They do not, by themselves, indicate immediate buying or selling of company stock.
Insider Transaction Report
- Award
Common Stock, $0.0001 par value
[F1][F2]2026-04-22+46,863→ 598,543 total - Award
Stock Option (Right to Buy)
[F3]2026-04-22+62,795→ 62,795 totalExercise: $5.04Exp: 2036-04-22→ Common Stock, $0.0001 par value (62,795 underlying)
Footnotes (3)
- [F1]On April 22, 2026, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on April 22, 2027, 15,621 shares on April 22, 2028 and 15,621 shares on April 22, 2029.
- [F2]Includes restricted stock units, which vest over various time periods.
- [F3]On April 22, 2026, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on April 22, 2027, 20,932 shares on April 22, 2028 and 20,931 shares on April 22, 2029.